rawfin.tv
Travere Therapeutics to Present at Stifel Immunology Forum
MarketsstocksAI Generated

Travere Therapeutics to Present at Stifel Immunology Forum

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Travere Therapeutics, Inc. (TVTX) announced its participation in the Stifel 2026 Virtual Immunology and Inflammation Forum. The company is scheduled to present at the industry event.

Travere TherapeuticsBiotechnologyInvestor RelationsHealthcare

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks